Trials / Recruiting
RecruitingNCT06692140
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention
Randomized Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention in an All Comer Population (The SORT OUT XII Trial)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,150 (estimated)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this randomized study is to compare the safety and efficacy of the ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent to the everolimus-eluting family stents (durable polymer everolimus-eluting Xience or Promus stents) in a population-based setting with coronary artery stenosis treated with percutaneous coronary intervention
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s) | Percutaneous coronary intervention with Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s) |
| DEVICE | PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s)) | Percutaneous coronary intervention with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s)) |
Timeline
- Start date
- 2024-11-16
- Primary completion
- 2028-07-01
- Completion
- 2032-07-01
- First posted
- 2024-11-18
- Last updated
- 2024-12-09
Locations
3 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06692140. Inclusion in this directory is not an endorsement.